The global pharmaceutical supply chain is a complex network vital for patient health, and its components are undergoing a period of significant transformation. In this webinar, Marken’s regulatory experts will share a comprehensive overview of the current state of these intricate systems, examining the confluence of evolving regulatory landscapes and the disruptive impact of recent US policy shifts. Speakers will delve into the intricacies of international sourcing, manufacturing, and distribution, highlighting the vulnerabilities and emerging opportunities that define today’s supply chain environment. 

A key focus will be on the profound influence on recent changes in U.S. policy, particularly the implementation of tariffs and their effects, such as the push for onshoring or nearshoring of pharmaceutical production. We will analyze how these measures are reshaping global trade flows, impacting drug costs, and potentially altering the structure of international logistics networks. The discussion will also address the ongoing challenges of maintaining stringent regulatory compliance across diverse jurisdictions – examining the implications of these policy changes for Good Manufacturing Practices, quality control, and the overall integrity of the pharmaceutical supply chain in a dynamic global environment. 

Speakers:

• Reynaldo Roman – Senior Director Regulatory Compliance, Marken
• Anna Cesar – Manager Regulatory Compliance EMEA, Marken